Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Dyadic International Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of DYAI: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders341330
Shares3.81M46.2K3.79M+24.4K (+0.6%)
Value$11.5M$139.0K$11.6M+$224.0K (+2.0%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held Dyadic International Inc at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to DYAI in Q2 2022
InstitutionSharesValue% of portfolio
Equitable Holdings, Inc.19,250$59.0K0.00%
Castle Wealth Management LLC3,500$11.0K0.01%

Sold out (2)

Institutions that held Dyadic International Inc at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of DYAI in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Dimensional Fund Advisors LP12,252$37.0K
Tower Research Capital LLC (TRC)1$0

Not filed for Q2 2022 yet (1)

Institutions that held Dyadic International Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DYAI in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Susquehanna Fundamental Investments, LLC46,215$139.0K